Riccardo Lencioni, Fabio Piscaglia, Luigi Bolondi 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Thomas Sersté1,2, Vincent Barrau3, Violaine Ozenne1, Marie Pierre Vullierme3, Pierre Bedossa5,6, Olivier Farges4, Dominique-Charles Valla1,6, Valérie Vilgrain3,6,
Differential Diagnosis
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Multiple single sections Turbo FLASH MR arterial portography in the detection of hepatic neoplasms  Hidemasa Uematsu, Hiroki Yamada, Norihiro Sadato,
Treatment of hepatocellular carcinoma
The Tail and the String Sign: New Sonographic Features of Subcutaneous Melanoma Metastasis  Antonio Corvino, Fabio Corvino, Orlando Catalano, Fabio Sandomenico,
Radioembolization for hepatocellular carcinoma
Conventional and contrast enhanced images of a lesion in the left lobe of the liver. (A) Conventional US scan of the right lobe shows marked steatosis.
Combined resection of aberrant right hepatic artery without anastomosis in panceaticoduodenectomy for pancreatic head cancer: A case report  Atsushi Nanashima,
Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator  E.A Henao, MD, W.Todd.
Update on ultrasound imaging of liver fibrosis
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Liver Masses: A Clinical, Radiologic, and Pathologic Perspective
State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives  Adrian Huber, Lukas.
Chemoembolization and Radioembolization for Hepatocellular Carcinoma
Volume 55, Issue 1, Pages (July 2011)
Hepatic adenomatosis in liver cirrhosis
Fig. 3. Sub-centimeter-sized HCC in 56-year-old man with chronic hepatitis B. Gadoxetic acid-enhanced MR image demonstrates 0.8-cm nodule (arrows) in right.
Multimodality Imaging of Tumour Thrombus
Neovascularization in acute venous thrombosis
Primovist, Eovist: What to expect?
Volume 68, Issue 4, Pages (April 2018)
What lessons have we learned in pediatric liver transplantation?
Functional imaging in liver tumours
ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: Is it really applicable?  Jian Wu, Wei Bai,
Volume 61, Issue 2, Pages (August 2014)
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Role of dual energy spectral computed tomography in characterization of hepatocellular carcinoma: Initial experience from a tertiary liver care institute 
Magnetic resonance imaging of liver tumors
Dual-Energy Multidetector Computed Tomography With Iodine Quantification in the Evaluation of Portal Vein Thrombosis: Is It Possible to Discard the Unenhanced.
Treatment of hepatocellular carcinoma
Volume 65, Issue 2, Pages (August 2016)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Detection and Characterization of Hepatocellular Carcinoma by Imaging
Why men are at higher risk for hepatocellular carcinoma?
Volume 62, Issue 3, Pages (March 2015)
Radioembolization for hepatocellular carcinoma
Volume 59, Issue 1, Pages (July 2013)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Volume 55, Issue 1, Pages (July 2011)
Volume 66, Issue 2, Pages (February 2017)
Volume 41, Issue 6, Pages (December 2004)
Fig. 2. HCC in 82-year-old man with chronic hepatitis C. A-C
The Role of Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma  Andy K.W. Chan, MD, FRCPC, Chris Hegarty, MB,
EUS targeting of vascular thrombosis: Risky business?
Vascularity of liver tumours and recent advances in Doppler ultrasound
Fibrosis in chronic liver diseases: diagnosis and management
Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma  Tao Jiang, Andrew X. Zhu, Dushyant V. Sahani 
Portal vein thrombosis, cirrhosis, and liver transplantation
Chetana Lim, Chady Salloum, Daniel Azoulay
Evolution of liver transplantation for hepatocellular carcinoma
Combined locoregional-immunotherapy for liver cancer
Volume 63, Issue 1, Pages (July 2015)
Primovist, Eovist: What to expect?
Multiple liver pseudotumors due to hepatic steatosis and fatty sparing: A non-invasive imaging approach  Andrea Delli pizzi, Domenico Mastrodicasa, Barbara.
Volume 49, Issue 1, Pages (July 2008)
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Digital subtract angiography and lipiodol deposits following embolization in cirrhotic nodules of LIRADS category ≥3  Zhen Kang, Nan Wang, Anhui Xu, Liang.
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Volume 50, Issue 1, Pages 4-6 (January 2009)
Fig. 1. Typical CEUS features of HCC in 60-year-old man with history of right hemihepatectomy for HCC.On arterial (A) and delayed (B) phases of CT, 2.3-cm.
Genetics of hepatocellular carcinoma: The next generation
Volume 41, Issue 3, Pages (September 2004)
A Case of Sciatic Arterio-venous Malformation
Aditya Agrawal, MS, FRCS, Richard Whitehouse, MD, FRCS, Robert W
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma  Riccardo Lencioni, Fabio Piscaglia, Luigi Bolondi  Journal of Hepatology  Volume 48, Issue 5, Pages 848-857 (May 2008) DOI: 10.1016/j.jhep.2008.02.005 Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Enhancement patterns of HCC at contrast-enhanced US and contrast-enhanced CT. The lesion shows clear-cut enhancement in the arterial phase both in the contrast-enhanced CT (a) and the contrast-enhanced US study (b). However, contrast wash-out in the portal venous phase is better detected on CT (c) than on US (d). In the late phase, the tumor is hypoenhanced both on CT (e) and on US (f). Journal of Hepatology 2008 48, 848-857DOI: (10.1016/j.jhep.2008.02.005) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Doppler US study of HCC. Baseline US scan (a) shows the tumor as hypoechoic nodule with infiltrative pattern (calipers). At Doppler US (b), flow in the segmental portal vein branch is reverted and shows a pulsatile pattern at spectral analysis, indicating the presence of arterio-portal fistula. Note that the peak of portal flow (shown below the zero line in the spectral tracing) is slightly delayed in comparison to that of the afferent hepatic arterial branch (above the zero line in the spectral tracing). Journal of Hepatology 2008 48, 848-857DOI: (10.1016/j.jhep.2008.02.005) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Non-invasive diagnosis of very-early HCC in cirrhosis. Baseline US shows 1.5-cm isoechoic nodule with hypoechoic halo (a). Contrast-enhanced US shows clear-cut enhancement in the arterial phase (b) with rapid wash-out in the portal venous phase (c). The same findings are observed on multidetector CT scans obtained in the arterial phase (d) and the portal venous phase (e). Journal of Hepatology 2008 48, 848-857DOI: (10.1016/j.jhep.2008.02.005) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Malignant portal vein thrombosis. Baseline US (a) shows tiny echoic thrombus (calipers) inside the left portal vein in patients with HCC. Signal from tissues is suppressed in the contrast-specific US image (b). Clear-cut contrast uptake of the thrombus is observed in the arterial phase of the contrast-enhanced study, suggesting the malignant nature of the thrombus (c). In the portal phase, the portal lumen fills with contrast, and the thrombus is no longer recognizable (d). Journal of Hepatology 2008 48, 848-857DOI: (10.1016/j.jhep.2008.02.005) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions